J R Gralow - JoVE Visualize

Showing results (11-20 of 21) with videos related to

Pageof 3

Sort By:

International Journal of Radiation Oncology, Biology, Physics|September 7, 2000

Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancerJ R Bellon, K L Lindsley, G K Ellis, et al.

Psycho-Oncology|July 29, 2016

Randomized controlled trial of the Valencia model of waking hypnosis plus CBT for pain, fatigue, and sleep management in patients with cancer and cancer survivorsM E Mendoza, A Capafons, J R Gralow, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001

[18F]fluoroestradiol radiation dosimetry in human PET studiesD A Mankoff, L M Peterson, T J Tewson, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancerR B Livingston, G K Ellis, J R Gralow, et al.

Blood|July 1, 1996

Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccinesM L Disis, H Bernhard, F M Shiota, et al.

Cancer Immunology, Immunotherapy : CII|July 1, 1997

Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatmentJ I Clark, R K Alpaugh, M von Mehren, et al.

Radiology|April 20, 1999

Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experienceP B Hathaway, D A Mankoff, K R Maravilla, et al.

Immunobiology|June 2, 2000

Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expressionH Bernhard, E S Huseby, S L Hand, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancerW B Eubank, D A Mankoff, J Takasugi, et al.

Breast Cancer Research and Treatment|July 10, 2016

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancerZ A Nahleh, W E Barlow, D F Hayes, et al.

Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:

Pageof 3

International Journal of Radiation Oncology, Biology, Physics|September 7, 2000

Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancerJ R Bellon, K L Lindsley, G K Ellis, et al.

Psycho-Oncology|July 29, 2016

Randomized controlled trial of the Valencia model of waking hypnosis plus CBT for pain, fatigue, and sleep management in patients with cancer and cancer survivorsM E Mendoza, A Capafons, J R Gralow, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001

[18F]fluoroestradiol radiation dosimetry in human PET studiesD A Mankoff, L M Peterson, T J Tewson, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancerR B Livingston, G K Ellis, J R Gralow, et al.

Blood|July 1, 1996

Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccinesM L Disis, H Bernhard, F M Shiota, et al.

Cancer Immunology, Immunotherapy : CII|July 1, 1997

Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatmentJ I Clark, R K Alpaugh, M von Mehren, et al.

Radiology|April 20, 1999

Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experienceP B Hathaway, D A Mankoff, K R Maravilla, et al.

Immunobiology|June 2, 2000

Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expressionH Bernhard, E S Huseby, S L Hand, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancerW B Eubank, D A Mankoff, J Takasugi, et al.

Breast Cancer Research and Treatment|July 10, 2016

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancerZ A Nahleh, W E Barlow, D F Hayes, et al.

Pageof 3